Renal involvement in eosinophilic granulomatosis with polyangiitis (EGPA): a multicentric retrospective study of 63 biopsy-proven cases.

OBJECTIVE Eosinophilic granulomatosis with polyangiitis (EGPA) is a systemic small-vessel vasculitis characterized by asthma, hypereosinophilia and ANCA positivity in 40% of patients. Renal involvement is rare and poorly described, leading to this renal biopsy-proven based study in a large EGPA cohort. METHODS We conducted a retrospective multicentre study including patients fulfilling the 1990 ACR criteria and/or the 2012 revised Chapel Hill Consensus Conference criteria for EGPA and/or the modified criteria of the MIRRA trial, with biopsy-proven nephropathy. RESULTS Sixty-three patients [27 women, median age 60 years (18-83)] were included. Renal disease was present at vasculitis diagnosis in 54 patients (86%). ANCA were positive in 53 cases (84%) with anti-MPO specificity in 44 (83%). All patients had late-onset asthma. Peripheral neuropathy was present in 29 cases (46%), alveolar haemorrhage in 10 (16%). The most common renal presentation was acute renal failure (75%). Renal biopsy revealed pauci-immune necrotizing GN in 49 cases (78%). Membranous nephropathy (10%) and membranoproliferative GN (3%) were mostly observed in ANCA-negative patients. Pure acute interstitial nephritis was found in six cases (10%); important interstitial inflammation was observed in 28 (44%). All patients received steroids with adjunctive immunosuppression in 54 cases (86%). After a median follow-up of 51 months (1-296), 58 patients (92%) were alive, nine (14%) were on chronic dialysis and two (3%) had undergone kidney transplantation. CONCLUSION Necrotizing pauci-immune GN is the most common renal presentation in ANCA-positive EGPA. ANCA-negative patients had frequent atypical renal presentation with other glomerulopathies such as membranous nephropathy. An important eosinophilic interstitial infiltration was observed in almost 50% of cases.

[1]  P. Merkel,et al.  Clinical associations of renal involvement in ANCA-associated Vasculitis. , 2020, Autoimmunity reviews.

[2]  J. Stone,et al.  All-cause and cause-specific mortality in ANCA-associated vasculitis: overall and according to ANCA type. , 2019, Rheumatology.

[3]  U. Specks,et al.  Exostosin 1/Exostosin 2-Associated Membranous Nephropathy. , 2019, Journal of the American Society of Nephrology : JASN.

[4]  U. Panzer,et al.  Development and validation of a renal risk score in ANCA-associated glomerulonephritis. , 2018, Kidney international.

[5]  A. Vaglio,et al.  Antineutrophil cytoplasmic antibody-associated vasculitides and IgG4-related disease: A new overlap syndrome. , 2017, Autoimmunity reviews.

[6]  S. Yancey,et al.  Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis , 2017, The New England journal of medicine.

[7]  J. Stone,et al.  Antineutrophil cytoplasmic antibody positivity in IgG4-related disease , 2016, Medicine.

[8]  Zhihong Liu,et al.  Long-term outcomes in antineutrophil cytoplasmic autoantibody–positive eosinophilic granulomatosis with polyangiitis patients with renal involvement: a retrospective study of 14 Chinese patients , 2016, BMC Nephrology.

[9]  Min Chen,et al.  Clinical and Immunologic Characteristics of Patients With ANCA-Associated Glomerulonephritis Combined With Membranous Nephropathy , 2015, Medicine.

[10]  A. Gallo,et al.  Churg-Strauss syndrome. , 2015, Autoimmunity reviews.

[11]  M. Solé,et al.  ANCA serotype and histopathological classification for the prediction of renal outcome in ANCA-associated glomerulonephritis. , 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[12]  Su-xia Wang,et al.  Assessment of KDIGO definitions in patients with histopathologic evidence of acute renal disease. , 2014, Clinical journal of the American Society of Nephrology : CJASN.

[13]  Harold I Feldman,et al.  KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[14]  R. Sinico,et al.  Renal involvement in anti-neutrophil cytoplasmic autoantibody associated vasculitis. , 2013, Autoimmunity reviews.

[15]  L. Bianchi,et al.  Anti-neutrophil cytoplasmic autoantibodies: methodological aspects and clinical significance in systemic vasculitis. , 2013, Autoimmunity reviews.

[16]  R. Waldherr,et al.  Tubular lesions predict renal outcome in antineutrophil cytoplasmic antibody-associated glomerulonephritis after rituximab therapy. , 2012, Journal of the American Society of Nephrology : JASN.

[17]  L. Guillevin,et al.  Churg-Strauss Syndrome: Clinical Symptoms, Complementary Investigations, Prognosis and Outcome, and Treatment , 2011, Seminars in respiratory and critical care medicine.

[18]  Irmgard Neumann,et al.  Histopathologic classification of ANCA-associated glomerulonephritis. , 2010, Journal of the American Society of Nephrology : JASN.

[19]  D A Bloch,et al.  The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). , 2010, Arthritis and rheumatism.

[20]  D A Bloch,et al.  The American College of Rheumatology 1990 criteria for the classification of vasculitis. Summary. , 2010, Arthritis and rheumatism.

[21]  M. Jallouli,et al.  Membranous glomerulopathy associated with idiopathic hypereosinophilic syndrome. , 2010, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.

[22]  G. Eknoyan.  Chronic kidney disease definition and classification: no need for a rush to judgment. , 2009, Kidney international.

[23]  David Steven Scott,et al.  Modification and validation of the Birmingham Vasculitis Activity Score (version 3) , 2008, Annals of the rheumatic diseases.

[24]  H. Raspe,et al.  EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis , 2006, Annals of the rheumatic diseases.

[25]  U. Maggiore,et al.  Renal involvement in Churg-Strauss syndrome. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[26]  L. Mouthon,et al.  Antineutrophil Cytoplasmic Antibodies and the ChurgStrauss Syndrome , 2005, Annals of Internal Medicine.

[27]  Laura Pavone,et al.  Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome. , 2005, Arthritis and rheumatism.

[28]  Y. Ubara,et al.  Membranous glomerulopathy induced by myeloperoxidase-anti-neutrophil cytoplasmic antibody-related crescentic glomerulonephritis. , 2005, Internal medicine.

[29]  A. Levey,et al.  A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.

[30]  M. Humbert,et al.  Revisiting the systemic vasculitis in eosinophilic granulomatosis with polyangiitis (Churg-Strauss): A study of 157 patients by the Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires and the European Respiratory Society Taskforce on eosinophilic granulomatosis with polyangiitis , 2017, Autoimmunity reviews.

[31]  P. Merkel,et al.  2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. , 2013, Arthritis and rheumatism.

[32]  C. Pusey,et al.  Renal involvement in Churg-Strauss syndrome. , 1990, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.